Nomura Securities Maintains a 'Reduce' on BB&T Capital (BBT); Update from Recent Meetings with Management
Get Alerts BBT Hot Sheet
Price: $32.07 --0%
Rating Summary:
14 Buy, 18 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 16 | New: 19
Rating Summary:
14 Buy, 18 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 16 | New: 19
Join SI Premium – FREE
Nomura Securities maintains a 'Reduce' on BB&T Capital (NYSE: BBT) price target of $25.00.
Nomura analyst, Brian Foran, "The company is focused on how it will adapt to an extended period of slow growth, low rates and new regulatory rules. Key points: a) efficiency, b) consolidation, and c) revenue opportunities from re-intermediation and market share gains. Similar to other banks we met recently, they felt there was a disconnect between the operating environment (tough but not terrible) and the recent stock price performance. They reiterated long-term ROE targets are possible even with Fed Funds at zero (but GDP growth does need to be normal)."
For more ratings news on BB&T Capital click here and for the rating history of BB&T Capital click here.
Shares of BB&T Capital closed at $21.66 yesterday.
Nomura analyst, Brian Foran, "The company is focused on how it will adapt to an extended period of slow growth, low rates and new regulatory rules. Key points: a) efficiency, b) consolidation, and c) revenue opportunities from re-intermediation and market share gains. Similar to other banks we met recently, they felt there was a disconnect between the operating environment (tough but not terrible) and the recent stock price performance. They reiterated long-term ROE targets are possible even with Fed Funds at zero (but GDP growth does need to be normal)."
For more ratings news on BB&T Capital click here and for the rating history of BB&T Capital click here.
Shares of BB&T Capital closed at $21.66 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Deutsche Bank Downgrades Workday (WDAY) to Hold
- Northland Upgrades Astera Labs (ALAB) to Outperform, 'Right Time, Customers, and Products'
- ADC Therapeutics (ADCT) PT Lowered to $5 at Guggenheim
Create E-mail Alert Related Categories
Analyst CommentsRelated Entities
BB&T Capital Markets, NomuraSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share